While oral administration of SARMs has been criticized for moderate to low bioavailability, injectable SARMs are not a superior alternative.

Injectable SARMs present significant risks of infection at the injection site. As I explained earlier in this book, the SARMs market is fraught with quality control issues. Many products sold online can be impure or adulterated, posing significant health risks. This uncertainty is amplified with injectable forms,